
A new security label from Schreiner MediPharm provides a clear first-opening indication for medicine vials. The tamper-evident label with clear and irreversible proof of first opening is designed to prevent the unauthorised reuse of original vials.
Drug counterfeiters often fill original drug containers with ineffective or harmful substitutes. It is often impossible to recognise that the containers have been tampered with. One of Schreiner MediPharm Tamper-evident label specially developed for vials with clear and irreversible proof of first opening can help prevent the unauthorised reuse of original containers and protect their integrity.
The new safety label encloses the vial up to the level of the cap. To open the vial a tear-off strip integrated into the label can be peeled off, which cannot be resealed unnoticed. After opening, a warning message also appears and clearly indicates the first opening. This first-opening indication can optionally be reinforced by a void effect: previously invisible lettering or symbols are irreversibly removed from an indicator field.
Customised solution for pharmaceutical manufacturers
For increased safety Authentication features for proof of authenticity integrated into the label can be customised. Special features are also possible, such as a removable documentation label, a viewing window for checking the contents, a light protection function for sensitive active ingredients or integrated NFC/RFID chips for digital applications.
The new tamper-evident label from Schreiner MediPharm is particularly suitable for small vials and is individually designed for the respective application. It can be processed in the normal labelling process in pharmaceutical production; Product branding and design are retained. Pharmaceutical manufacturers receive a solution that is customised precisely to their requirements, fits easily into their production processes and helps to secure their supply chain.
For medical staff, the label is not only easy to use, it also shows at first glance whether it is an originally sealed medication is concerned. In this way, patients can be protected from the possible administration of ineffective or harmful medications.
Source: Schreiner MediPharm
Schreiner MediPharm - More news


Functional label for modern therapies

Digital tracking solution from Schreiner MediPharm optimises clinical trials

NFC labels offer protection against counterfeit medicines

Blister-free packaging for prefilled syringes

